In this context, our finding of higher mGluR5 expression on H-RS cells from EBV-negative tumors could be a hint to mGluR5 upregulation being one of many oncogenic alterations and tumor promoting factors described in the HL subtype. The gene discussed is GRM5; the disease is Hodgkins lymphoma.